In-vivo indices of CYP2D6 activity: Comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma

European Journal of Clinical Pharmacology

Volumn 56, Issue 9-10, 2000, Pages 651-657

  Chladek J ^a   Zimova G ^a   Beranek M ^b   Martinkova J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE;

ADULT; ARTICLE; CAUCASIAN; CZECH REPUBLIC; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC RATE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ALLELES; ANTITUSSIVE AGENTS; CYTOCHROME P-450 CYP2D6; DEXTROMETHORPHAN; FEMALE; HUMANS; MALE; PHENOTYPE;

EID: 0034468888     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000218     Document Type: Article

References (31)

1. Polymorphism of the cytochrome P450 CYP2D6 gone in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
2. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population
3. 1 activity
4. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans
5. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
6. Characterization of dextromethorphan N-demethylation by human liver microsomes
7. Multiple human cytochromes contribute to biotransforrnation of dextromethorphan in-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A
8. Metabolism of dextromethorphan in vitro: Involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1
9. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation
10. Dextromethorphan: Polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man
11. CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication
12. Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity
13. Intraindividual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects
14. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
15. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
16. Comparison of three CYP2D6 probe substrates and genotype in Ghanians. Chinese and Caucasians
17. Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping
18. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping
19. Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population
20. Interethnic differences in drug metabolism: Influence of genetic and environmental factors on debrisoquine hydroxylation phenotype
21. Induction of CYP2D6 in pregnancy
22. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
23. Dextromethorphan O-demethylation and dextrorphan glucuronidation in French population
24. Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distribution analysis
25. Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation
26. Polymorphic drug oxidation: Pharmacokinetic basis and comparison of experimental indices
27. Invivo indices of enzyme activity: The effect of renal impairment on the assessment of CYP2D6 activity
28. Assessment of CYP2D6 and CYP2CI9 activity in vivo in humans: A cocktail study with dextromethorphan and chloroguanide alone and in combination
29. Polymorphism of dextromethorphan oxidation in South Indian subjects
30. Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan
31. The influence of C YP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans